2.50
Hdl Handle:
http://hdl.handle.net/2336/31292
Title:
Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy
Authors:
Bragadottir, G; Onundarson, P T
Citation:
Haemophilia. 2002, 8(6):832-3
Issue Date:
1-Nov-2002
Abstract:
Examines the use of the cyclo-oxygenase 2 inhibitor anti-inflammatory drug rofecoxib in patients with hemophilic arthropathy. Case study of a patient of severe hemophilia; Features of the drug; Reduction of symptoms in the patient.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=7699260&site=ehost-live

Full metadata record

DC FieldValue Language
dc.contributor.authorBragadottir, G-
dc.contributor.authorOnundarson, P T-
dc.date.accessioned2008-07-08T13:10:31Z-
dc.date.available2008-07-08T13:10:31Z-
dc.date.issued2002-11-01-
dc.date.submitted2008-07-08-
dc.identifier.citationHaemophilia. 2002, 8(6):832-3en
dc.identifier.issn1351-8216-
dc.identifier.pmid12410658-
dc.identifier.doi10.1046/j.1365-2516.2002.00683_2.x-
dc.identifier.urihttp://hdl.handle.net/2336/31292-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractExamines the use of the cyclo-oxygenase 2 inhibitor anti-inflammatory drug rofecoxib in patients with hemophilic arthropathy. Case study of a patient of severe hemophilia; Features of the drug; Reduction of symptoms in the patient.en
dc.language.isoenen
dc.publisherBlackwell Scienceen
dc.relation.urlhttp://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=7699260&site=ehost-liveen
dc.subject.meshAdulten
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidalen
dc.subject.meshCyclooxygenase 2en
dc.subject.meshCyclooxygenase 2 Inhibitorsen
dc.subject.meshCyclooxygenase Inhibitorsen
dc.subject.meshHemophilia Aen
dc.subject.meshHumansen
dc.subject.meshIsoenzymesen
dc.subject.meshJoint Diseasesen
dc.subject.meshLactonesen
dc.subject.meshMaleen
dc.subject.meshMembrane Proteinsen
dc.subject.meshProstaglandin-Endoperoxide Synthasesen
dc.subject.meshSulfonesen
dc.titleFactor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathyen
dc.typeArticleen
dc.contributor.departmentDepartment of Laboratory Haematology and Haemostasis Center, Landspitali University Hospital, 101 Reykjavik, Iceland.en
dc.identifier.journalHaemophilia : the official journal of the World Federation of Hemophiliaen

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.